Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.6% lower and the iShares Biotechnology ETF (IBB) down 0.5%.
Novo Nordisk (NVO) said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.
Moderna (MRNA) shares were down nearly 5% amid the company's plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.
HealthEquity (HQY) stock was down more than 5% even after the company reported higher fiscal Q2 adjusted earnings and revenue.